<- Go Home
Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.
Market Cap
$347.8M
Volume
49.4K
Cash and Equivalents
$11.7M
EBITDA
-$36.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$4.69
52 Week Low
$2.14
Dividend
N/A
Price / Book Value
4.02
Price / Earnings
-8.45
Price / Tangible Book Value
4.02
Enterprise Value
$281.4M
Enterprise Value / EBITDA
-7.99
Operating Income
-$37.5M
Return on Equity
43.83%
Return on Assets
-22.66
Cash and Short Term Investments
$79.7M
Debt
$13.3M
Equity
$86.6M
Revenue
N/A
Unlevered FCF
-$17.5M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium